Our Story

Buccaline was originally developed in the 1950s in Switzerland at the Swiss Serum & Vaccine Institute as an alternative to live, injectable vaccines. Buccaline was then trialled extensively over the next 20 years and shown to be the safest and most effective product at addressing the bacterial complications of colds or secondary infections caused by respiratory illnesses.

In the late 1960’s Prof. C. Melino from the Department of Health of the Transport Ministry in Rome conducted a large controlled trial on employees of the Italian National Railways. The trial compared the instances of workdays lost due to sickness between a group that had taken Buccaline and a control group. The results concluded that the control group which had not taken Buccaline had on average 3.35 times higher rate of absence than those that had. And that’s why we say ‘When there’s no time for sick days take Buccaline’.

For over 50 years Buccaline has been sold in many countries throughout the world with millions of satisfied customers.